Prostate sarcoma.
malignancy
prostate
prostatectomy
sarcoma
Journal
IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
25
10
2022
accepted:
03
02
2023
medline:
5
5
2023
pubmed:
5
5
2023
entrez:
5
5
2023
Statut:
epublish
Résumé
This report is intended to provide insight into the presentation, diagnosis, and treatment of prostatic sarcomas. A literature review is included to compare variables in demographics, histology, prognosis, and treatment strategies among previously reported incidences. In this case, we have a 72-year-old man who initially presented with symptomatic nephrolithiasis that led to further workup. Magnetic resonance imaging revealed an enlarged, heterogeneous prostate with a dominant mass in the left lobe. A biopsy of the prostate revealed a high-grade, undifferentiated sarcoma in the left lobe along with concomitant adenocarcinoma in the right lobe. The patient underwent a radical prostatectomy, which according to existing literature remains the most effective treatment strategy. Staging is the most important prognostic indicator, making this cancer particularly dangerous as presenting symptoms are highly variable among patients.
Identifiants
pubmed: 37144084
doi: 10.1002/iju5.12578
pii: IJU512578
pmc: PMC10151200
doi:
Types de publication
Case Reports
Langues
eng
Pagination
165-168Informations de copyright
© 2023 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Clin Radiol. 2009 Feb;64(2):171-7
pubmed: 19103347
Urology. 2014 Sep;84(3):624-8
pubmed: 25168544
Korean J Urol. 2014 Dec;55(12):797-801
pubmed: 25512813
Zhonghua Bing Li Xue Za Zhi. 2011 Nov;40(11):749-53
pubmed: 22336158
Cancer. 1995 Oct 15;76(8):1422-7
pubmed: 8620418